BIOMAT Database Logo BIOMAT Database Logo

Dual aromatase-steroid sulfatase inhibitors. 2007

L W Lawrence Woo, and Christian Bubert, and Oliver B Sutcliffe, and Andrew Smith, and Surinder K Chander, and Mary F Mahon, and Atul Purohit, and Michael J Reed, and Barry V L Potter
Medicinal Chemistry, Department of Pharmacy & Pharmacology and Sterix Limited, University of Bath, Claverton Down, Bath, BA2 7AY, UK.

By introducting the steroid sulfatase inhibitory pharmacophore into aromatase inhibitor 1 (YM511), two series of single agent dual aromatase-sulfatase inhibitors (DASIs) were generated. The best DASIs in vitro (JEG-3 cells) are 5, (IC50(aromatase) = 0.82 nM; IC50(sulfatase) = 39 nM), and 14, (IC50(aromatase) = 0.77 nM; IC50(sulfatase) = 590 nM). X-ray crystallography of 5, and docking studies of selected compounds into an aromatase homology model and the steroid sulfatase crystal structure are presented. Both 5 and 14 inhibit aromatase and sulfatase in PMSG pretreated adult female Wistar rats potently 3 h after a single oral 10 mg/kg dose. Almost complete dual inhibition is observed for 5 but the levels were reduced to 85% (aromatase) and 72% (sulfatase) after 24 h. DASI 5 did not inhibit aldosterone synthesis. The development of a potent and selective DASI should allow the therapeutic potential of dual aromatase-sulfatase inhibition in hormone-dependent breast cancer to be assessed.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D013449 Sulfonamides A group of compounds that contain the structure SO2NH2. Sulfonamide,Sulfonamide Mixture,Sulfonamide Mixtures,Mixture, Sulfonamide,Mixtures, Sulfonamide
D014230 Triazoles Heterocyclic compounds containing a five-membered ring with two carbon atoms and three nitrogen atoms with the molecular formula C2H3N3. Triazole
D017208 Rats, Wistar A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain. Wistar Rat,Rat, Wistar,Wistar Rats
D043266 Steryl-Sulfatase An arylsulfatase with high specificity towards sulfated steroids. Defects in this enzyme are the cause of ICHTHYOSIS, X-LINKED. 3 Beta-Hydroxysteroid Sulfate Sulfatase,Arylsulfatase C,Arylsulphatase C,Cholesterol Sulfatase,Cholesterol Sulfate Sulfatase,DHEA Sulfatase,Dehydroepiandrosterone Sulfate Sulfatase,Estrone Sulfate Sulfatase,Estrone Sulfate Sulfohydrolase,Steroid Sulfatase,Steroid Sulfohydrolase,Steroid Sulphatase,Sterol Sulfatase,Sterylsulfatase,3 Beta Hydroxysteroid Sulfate Sulfatase,Steryl Sulfatase,Sulfatase, Cholesterol,Sulfatase, Cholesterol Sulfate,Sulfatase, DHEA,Sulfatase, Dehydroepiandrosterone Sulfate,Sulfatase, Estrone Sulfate,Sulfatase, Steroid,Sulfatase, Sterol,Sulfate Sulfatase, Cholesterol,Sulfate Sulfatase, Dehydroepiandrosterone,Sulfate Sulfatase, Estrone,Sulfate Sulfohydrolase, Estrone,Sulfohydrolase, Estrone Sulfate,Sulfohydrolase, Steroid,Sulphatase, Steroid

Related Publications

L W Lawrence Woo, and Christian Bubert, and Oliver B Sutcliffe, and Andrew Smith, and Surinder K Chander, and Mary F Mahon, and Atul Purohit, and Michael J Reed, and Barry V L Potter
Aromatase and dual aromatase-steroid sulfatase inhibitors from the letrozole and vorozole templates.
August 2011, ChemMedChem,
L W Lawrence Woo, and Christian Bubert, and Oliver B Sutcliffe, and Andrew Smith, and Surinder K Chander, and Mary F Mahon, and Atul Purohit, and Michael J Reed, and Barry V L Potter
Highly potent first examples of dual aromatase-steroid sulfatase inhibitors based on a biphenyl template.
March 2010, Journal of medicinal chemistry,
L W Lawrence Woo, and Christian Bubert, and Oliver B Sutcliffe, and Andrew Smith, and Surinder K Chander, and Mary F Mahon, and Atul Purohit, and Michael J Reed, and Barry V L Potter
Chiral aromatase and dual aromatase-steroid sulfatase inhibitors from the letrozole template: synthesis, absolute configuration, and in vitro activity.
July 2008, Journal of medicinal chemistry,
L W Lawrence Woo, and Christian Bubert, and Oliver B Sutcliffe, and Andrew Smith, and Surinder K Chander, and Mary F Mahon, and Atul Purohit, and Michael J Reed, and Barry V L Potter
Design and synthesis of carbon-11-labeled dual aromatase-steroid sulfatase inhibitors as new potential PET agents for imaging of aromatase and steroid sulfatase expression in breast cancer.
November 2009, Steroids,
L W Lawrence Woo, and Christian Bubert, and Oliver B Sutcliffe, and Andrew Smith, and Surinder K Chander, and Mary F Mahon, and Atul Purohit, and Michael J Reed, and Barry V L Potter
First crystal structures of human carbonic anhydrase II in complex with dual aromatase-steroid sulfatase inhibitors.
May 2005, Biochemistry,
L W Lawrence Woo, and Christian Bubert, and Oliver B Sutcliffe, and Andrew Smith, and Surinder K Chander, and Mary F Mahon, and Atul Purohit, and Michael J Reed, and Barry V L Potter
Steroid sulfatase inhibitors.
July 2004, Medicinal research reviews,
L W Lawrence Woo, and Christian Bubert, and Oliver B Sutcliffe, and Andrew Smith, and Surinder K Chander, and Mary F Mahon, and Atul Purohit, and Michael J Reed, and Barry V L Potter
Aromatase and steroid sulfatase from human placenta.
January 2023, Methods in enzymology,
L W Lawrence Woo, and Christian Bubert, and Oliver B Sutcliffe, and Andrew Smith, and Surinder K Chander, and Mary F Mahon, and Atul Purohit, and Michael J Reed, and Barry V L Potter
Dual aromatase-steroid sulfatase inhibitors (DASI's) for the treatment of breast cancer: a structure guided ligand based designing approach.
December 2023, Journal of biomolecular structure & dynamics,
L W Lawrence Woo, and Christian Bubert, and Oliver B Sutcliffe, and Andrew Smith, and Surinder K Chander, and Mary F Mahon, and Atul Purohit, and Michael J Reed, and Barry V L Potter
Steroid derivatives as inhibitors of steroid sulfatase.
September 2013, The Journal of steroid biochemistry and molecular biology,
L W Lawrence Woo, and Christian Bubert, and Oliver B Sutcliffe, and Andrew Smith, and Surinder K Chander, and Mary F Mahon, and Atul Purohit, and Michael J Reed, and Barry V L Potter
Development of steroid sulfatase inhibitors.
July 2011, Molecular and cellular endocrinology,
Copied contents to your clipboard!